Ajay Kakkar

Years Active: 2022-2022
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

John William Eikelboom, Jacqueline Bosch, Stuart J Connolly, Jessica Tyrwitt, Keith A A Fox, Eva Muehlhofer, Christoph Neumann, Christoph Tasto, Shrikant I Bangdiwala, Rafael Diaz, Marco Alings, Gilles R Dagenais, Darryl P Leong, Eva M Lonn, Alvaro Avezum, Leopoldo Soares Piegas, Petr Widimsky, Alexander N Parkhomenko, Deepak L Bhatt, Kelley R H Branch, Jeffrey L Probstfield, Patricio Lopez-Jaramillo, Lars Rydén, Nana Pogosova, Katalin Keltai, Matyas Keltai, Georg Ertl, Stefan Stoerk, Antonio L Dans, Fernando Tomás Lanas Zanetti, Yan Liang, Jun Zhu, Christian Torp-Pedersen, Aldo Pietro Maggioni, Patrick J Commerford, Tomasz J Guzik, Thomas Vanassche, Peter Verhamme, Martin O'Donnell, Andrew M Tonkin, John D Varigos, Dragos Vinereanu, Camillo Felix, Jae-Hyung Kim, Khairul S Ibrahim, Basil S Lewis, Kaj P Metsarinne, Victor Aboyans, Phillippe Gabriel Steg, Masatsugu Hori, Ajay Kakkar, Sonia S Anand, Andre Lamy, Mukul Sharma, Salim Yusuf
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. European heart journal. Cardiovascular pharmacotherapy 8 (8) (2022)

Ajay Kakkar.css-eqlu8i{font-size:small;padding-left:4px;}